Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer

(MedPage Today) — SAN FRANCISCO — A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally advanced or metastatic penile cancer, according to findings from a phase II study….